Key insights
- Rocket Lab reported third quarter EPS of $-0.120, missing analyst estimates by $0.05, but revenue of $268M topped consensus estimates. The company provided Q4 2026 revenue guidance of $270M-$290M, exceeding analyst expectations. Rocket Lab's stock has seen a -26.520% decline in the last three months but is up 13.410% over the past twelve months. The company's financial health score is rated as 'fair performance'.
Investing.com - Rocket Lab (NASDAQ: RKLB) reported third quarter EPS of $-0.120, $0.05 worse than the analyst estimate of $-0.070. Revenue for the quarter came in at $268M versus the consensus estimate of $257.17M.
Rocket Lab sees Q4 2026 revenue of $270.000M-$290.000M versus the analyst consensus of $265.500M.
Rocket Lab’s stock price closed at $58.86. It is down -26.520% in the last 3 months and up 13.410% in the last 12 months.
Rocket Lab saw 2 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Rocket Lab’s stock price’s past reactions to earnings here.
According to InvestingPro, Rocket Lab’s Financial Health score is "fair performance".
Check out Rocket Lab’s recent earnings performance, and Rocket Lab’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
That's one option. But ProPicks AI re-evaluates RKLB alongside thousands of other companies every month, using 100+ financial metrics, and it may have found you a better stock. ProPicks AI looks past headlines and Reddit to fundamentals, momentum and valuation. You get the rationale behind every pick, so you can check the logic before you act on it. Over three years, our strategies have returned 2.3X the S&P 500's returns. Find out whether RKLB made this month's lists, and which stocks in the same space did. Now 55% off for Black Friday early birds.